These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8356609)

  • 21. Antihistamines as prophylaxis against side reactions to intravenous fluorescein.
    Ellis PP; Schoenberger M; Rendi MA
    Trans Am Ophthalmol Soc; 1980; 78():190-205. PubMed ID: 7257056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular collapse following intravenous fluorescein sodium.
    Baraka A; Moghrabi R; Sibai AN; Haidar J
    Middle East J Anaesthesiol; 1986 Jun; 8(5):437-40. PubMed ID: 3747967
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical evaluation of fluorescein 25%.
    Willerson D; Tate GW; Baldwin HA; Hearnsberger PL
    Ann Ophthalmol; 1976 Jul; 8(7):833-4, 837-41. PubMed ID: 962260
    [No Abstract]   [Full Text] [Related]  

  • 24. Phototoxic reactions caused by sodium fluorescein.
    Danis RP; Stephens T
    Am J Ophthalmol; 1997 May; 123(5):694-6. PubMed ID: 9152079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Report on the presence of a toxic substance, dimethyl formamide, in sodium fluorescein used for fluorescein angiography.
    Jacob JS; Rosen ES; Young E
    Br J Ophthalmol; 1982 Sep; 66(9):567-8. PubMed ID: 7104275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analytical interference in the therapeutic drug monitoring of methotrexate.
    Oudart JB; Marquet B; Feliu C; Gozalo C; Djerada Z; Millart H
    Ann Biol Clin (Paris); 2016 Jun; 74(3):333-7. PubMed ID: 27101631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse reactions during intravenous fluorescein angiography.
    Marcus DF; Bovino JA; Williams D
    Arch Ophthalmol; 1984 Jun; 102(6):825. PubMed ID: 6732561
    [No Abstract]   [Full Text] [Related]  

  • 28. [Usefulness of the prick test for anaphylactoid reaction in intravenous fluorescein administration].
    Matsuura M; Ando F; Fukumoto K; Kyogane I; Torii Y; Matsuura M
    Nippon Ganka Gakkai Zasshi; 1996 Apr; 100(4):313-7. PubMed ID: 8644545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation between methods of plasma cyclosporine determination by TDx and RIA cyclo-Trac 125].
    Camsonne R; Albessard F; Fusibet H; Bigot MC; Moulin MA
    Therapie; 1991; 46(6):497-8. PubMed ID: 1819156
    [No Abstract]   [Full Text] [Related]  

  • 30. Photosensitivity reaction to intravenously administered fluorescein.
    Lentner A; Böhler U
    Photodermatol Photoimmunol Photomed; 1995 Aug; 11(4):178-9. PubMed ID: 8850253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A contraindication to injection of intravenous fluorescein.
    Weaver DT; Herman DC
    Am J Ophthalmol; 1990 Apr; 109(4):490-1. PubMed ID: 2330960
    [No Abstract]   [Full Text] [Related]  

  • 32. An evaluation of the cyclosporine parent-compound-specific whole blood TDx assay.
    Pescovitz MD; Book BK; Pollard SG; Milgrom ML; Leapman SB; Filo RS
    Clin Transplant; 1992 Feb; 6(1):43-7. PubMed ID: 10147649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence polarization immunoassays and related methods for simple, high-throughput screening of small molecules.
    Smith DS; Eremin SA
    Anal Bioanal Chem; 2008 Jul; 391(5):1499-507. PubMed ID: 18264817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma complement and histamine changes after intravenous administration of sodium fluorescein.
    Arroyave CM; Wolbers R; Ellis PP
    Am J Ophthalmol; 1979 Apr; 87(4):474-9. PubMed ID: 87131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaphylactoid reaction to intravenously administered fluorescein.
    LaPiana FG; Penner R
    Arch Ophthalmol; 1968 Feb; 79(2):161-2. PubMed ID: 5635339
    [No Abstract]   [Full Text] [Related]  

  • 36. Establishment of norvancomycin fluorescence polarization immunoassay for therapeutic drug monitoring.
    Wu XJ; Zhang J; Yu JC; Cao GY; Shi YG; Zhang YY; Wang MG
    J Antibiot (Tokyo); 2012 Jan; 65(1):35-9. PubMed ID: 22045420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescein angiography complication survey.
    Yannuzzi LA; Rohrer KT; Tindel LJ; Sobel RS; Costanza MA; Shields W; Zang E
    Ophthalmology; 1986 May; 93(5):611-7. PubMed ID: 3523356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study of two techniques of ciclosporine monitoring].
    Charfi R; El Jebari H; Gaïes E; Charfi O; Jebabli N; Thouraya R; Ben Messaouda M; Lakhal M; Klouz A; Salouage I; Trabelsi S
    Ann Biol Clin (Paris); 2015; 73(6):717-22. PubMed ID: 26635051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interference by intravenous fluorescein with drug assays in the Abbott TDx.
    Schneider MC; Rayburn BK; Frye R
    Clin Chem; 1983 Nov; 29(11):2001. PubMed ID: 6627654
    [No Abstract]   [Full Text] [Related]  

  • 40. Performance evaluation of the new ADVIA Centaur system cyclosporine assay (single-step extraction).
    Soldin SJ; Hardy RW; Wians FH; Balko JA; Mendu DR; Chaffin CH; Streit F; Barbarakis M; Martel J; Canfield W; Levy HR; Oellerich M
    Clin Chim Acta; 2010 Jun; 411(11-12):806-11. PubMed ID: 20188087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.